Manhattan Scientifics, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 97,000. Operating loss was USD 1.025 million compared to USD 1.448 million a year ago. Net loss was USD 1.222 million compared to USD 8.334 million a year ago.